STAT+: Swing Therapeutics raises $11 million, adds former Pear CEO to board
Former Pear CEO joins Swing board — did he invest? My colleague Allison DeAngelis spotted a familiar character pop up in a fresh SEC filing from Swing Therapeutics, developer of…
